A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.
TAMPA, FL / ACCESS Newswire / February 5, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC PINK:CTTH) is pleased to announce adding Dr. Katherine Cole as an Independent Director for CTT.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback